Indoxyl sulphate and kidney disease: Causes, consequences and interventions

Author:

Ellis Robert J1,Small David M1,Vesey David A12,Johnson David W12,Francis Ross2,Vitetta Luis34,Gobe Glenda C1,Morais Christudas1

Affiliation:

1. Centre for Kidney Disease Research; Translational Research Institute; School of Medicine; University of Queensland; Brisbane Queensland Australia

2. Department of Renal Medicine; University of Queensland at Princess Alexandra Hospital; Brisbane Queensland Australia

3. Sydney Medical School - Medical Sciences; Medlab; Sydney New South Wales Australia

4. Medlab Clinical Ltd.; Medlab; Sydney New South Wales Australia

Publisher

Wiley

Subject

Nephrology,General Medicine

Reference60 articles.

1. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Disease: Improving Global Outcomes CKD Work Group;Kidney Int. Suppl.,2013

2. Prevalence of chronic kidney disease in population-based studies: Systematic review;Zhang;BMC Public Health,2008

3. Normal and pathologic concentrations of uremic toxins;Duranton;J. Am. Soc. Nephrol.,2012

4. Uremic toxins: What are they? An integrated overview of pathobiology and classification;Glassock;J. Ren. Nutr.,2008

5. Targeting protein-bound uremic toxins in chronic kidney disease;Niwa;Expert Opin. Ther. Targets,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3